Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling pathways

Items 1531-1540 of 5284

Page
per page
  1. Tianagliflozin
    BA6951 Tianagliflozin
    Summary: Tianagliflozin is a sodium/glucose cotransporter protein 2 inhibitor.
  2. Remogliflozin
    BA6952 Remogliflozin
    Summary: Remogliflozin is a potent and selective inhibitor of the human and rat sodium-glucose cotransporter 2.
  3. T-1095
    BA6953 T-1095
    Summary: T-1095 is a selective and orally active inhibitor of Na-glucose cotransporter proteins with 22.8 μM and 2.3 μM against human SGLT1 and SGLT2, respectively.
  4. Luseogliflozin
    BA6954 Luseogliflozin
    Summary: Luseogliflozin (TS071) is a potent, selective, and orally active inhibitor of sodium-glucose cotransporter protein 2.
  5. HSK0935
    BA6955 HSK0935
    Summary: HSK0935 is a potent, highly selective, orally available inhibitor.
  6. LTGO-33
    BA6956 LTGO-33
    Summary: LTGO-33 is a potent and selective voltage-gated sodium channel inhibitor.
  7. TPC2-A1-P
    BA6957 TPC2-A1-P
    Summary: A potent, membrane-permeable two-pore channel 2 (TPC2) agonist that mimics the physiological actions of PI(3,5)P2 for endolysosomal Ca2+ release
  8. Suzetrigine
    BA6958 Suzetrigine
    Summary: An orally active and highly selective NaV1.8 inhibitor that acts as an analgesic for acute pain
      ≥52.7 mg/mL
  9. Zandatrigine
    BA6959 Zandatrigine
    Summary: A selective, orally active, blood-brain barrier-penetrant voltage-gated sodium channel NaV1.6 (SCN8A) inhibitor
  10. PF-01247324
    BA6960 PF-01247324
    Summary: PF-01247324 is a selective and orally active channel blocker.

Items 1531-1540 of 5284

Page
per page